Article Details
Retrieved on: 2021-09-08 15:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
NEW YORK – Erasca on Wednesday said it has partnered with Pfizer on a trial evaluating its ERK1/2 inhibitor ERAS-007 with Pfizer's encorafenib ...
Article found on: www.precisiononcologynews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here